David A. Siegel Abbott Laboratories Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Abbott Laboratories stock. As of the latest transaction made, Two Sigma Advisers, LP holds 2,019,000 shares of ABT stock, worth $210 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

2,019,000

Previous 28,800 6910.42%

Holding current value

$210 Million

Previous $3.17 Million 7139.09%

% of portfolio

0.54%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $218 Million - $241 Million	1,990,200 Added 6910.42%	2,019,000 $229 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $35.2 Million - $43.1 Million	-390,400 Reduced 93.13%	28,800 $3.17 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $25 Million - $30.1 Million	262,200 Added 167.01%	419,200 $40.6 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $41 Million - $45.7 Million	-407,300 Reduced 72.18%	157,000 $17.1 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $9.96 Million - $11.7 Million	102,800 Added 22.28%	564,300 $57.1 Million

Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $41.3 Million - $48.5 Million	-434,900 Reduced 48.52%	461,500 $50.7 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $43.9 Million - $50.8 Million	453,600 Added 102.44%	896,400 $86.7 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $14.4 Million - $17.4 Million	140,900 Added 46.67%	442,800 $48.1 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $1.2 Million - $1.46 Million	-10,500 Reduced 3.36%	301,900 $35.7 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $201 Million - $246 Million	-1,738,861 Reduced 84.77%	312,400 $44 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $139 Million - $154 Million	-1,191,900 Reduced 36.75%	2,051,261 $242 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $299 Million - $352 Million	2,829,600 Added 684.2%	3,243,161 $376 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $15.7 Million - $18.5 Million	144,500 Added 53.71%	413,561 $49.6 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $7.4 Million - $8.07 Million	70,500 Added 35.51%	269,061 $29.5 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $136 Million - $165 Million	-1,480,000 Reduced 88.17%	198,561 $21.6 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $86.6 Million - $111 Million	1,130,761 Added 206.42%	1,678,561 $153 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $23.6 Million - $34.5 Million	375,039 Added 217.09%	547,800 $43.2 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $5.16 Million - $5.75 Million	65,761 Added 61.46%	172,761 $15 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $7.32 Million - $7.93 Million	89,400 Added 507.95%	107,000 $8.95 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $1.28 Million - $1.5 Million	17,600 New	17,600 $1.48 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $4.69 Million - $5.65 Million	-77,060 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $4.44 Million - $4.9 Million	77,060 New	77,060 $4.7 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $7.76 Million - $8.78 Million	-137,936 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $7.4 Million - $7.93 Million	137,936	137,936 $7.87 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account